Bristol Myers Squibb (BMY) supplied to purchase Mirati Therapeutics (MRTX) for as much as $5.8 billion, however MRTX inventory tumbled Monday on the lowball bid.XThe deal values Mirati inventory at $58 per share,...
The “Rookie to Actual Property Investor in 90 Days” collection is again, and we’re checking in with three mentees as they go from newbies to high-net-worth by way of actual property! Our mentees...
